← Back to Category — Healthcare & Public Health
Let the FDA Spend their money
AKA “FDA Efficiency Act”
Which agency/agencies promulgated the regulation? *
Department of Health & Human Services (HHS) / Food & Drug Administration (FDA)
• 21 U.S.C. § 379h(c)(4) – the Prescription Drug User Fee Act (PDUFA) operating‐reserve requirement (10–14 week carryover of user‐fee balances).
—OPTIONAL--
Notice of Proposed Rulemaking
PDUFA User‐Fee Operating‐Reserve Requirement
The mandatory 10–14 week operating reserve in 21 U.S.C. § 379h(c)(4) forces FDA to hold user-fee revenues in reserve, triggering end-of-year hiring freezes and resource shortfalls. Rescinding this requirement would allow carryforward of unobligated fee revenues, supporting continuous staffing, training, and critical infrastructure investments.
Department of Health & Human Services
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
492-4305 (410) 786-1524 (410) 786-8437
When PDUFA was first authorized in 1992 (and reauthorized subsequently), Congress required FDA to maintain a 10–14 week operating reserve of user fees (21 U.S.C. § 379h(c)(4)). While intended to ensure liquidity, this floor leads to periodic freezes in hiring and contracting, reducing review capacity at precisely the moments when industry workloads surge.
Striking § 379h(c)(4) removes the artificial floor on carryforward, allowing FDA to obligate fee revenues as needed across fiscal years—smoothing staffing levels, avoiding seasonal slowdowns, and ensuring reviewers, inspectors, and policy staff are onboard year-round.
— 21 U.S.C. § 379h(c)(4) deleted; no statutory operating-reserve requirement. FDA may carry forward and obligate user fees according to operational needs without a mandated balance floor.
All other PDUFA provisions remain in effect.
Robert F. Kennedy Jr.
Secretary of Health and Human Services